Short acting opioids: Fentanyl, Hydromorphone for Tonsillitis

"Children aged 3 to 17 years old may be eligible to participate in this study, based on the inclusion criteria."

"This research is looking for participants and was last updated on the 8th of April, 2022 according to clinicaltrials.gov."

"That is correct, the online information portal clinicaltrials.gov has verified that this study is looking for 60 individuals to take part in research trials at a single site. The original posting was on April 8th, 2022 and there have been no updates since then."

"Sixty patients that currently experience pain and meet the following age, procedure, and consent criteria are being enrolled in this clinical trial: 3-17 years old, scheduled for tonsillectomy +/- adenoidectomy, able to provide informed consent / assent."

"While there is some data backing the safety of short acting opioids like Fentanyl and Hydromorphone, there is no evidence yet to support their efficacy. Our team has given it a 2."

"The primary outcome of this study, which will be administered over a period of 7 days post-surgery, is to measure the total amount of opioids consumed by patients in the long-acting opioid group. Secondary outcomes include assessing pain levels in the short-acting opioid group using the Numeric Pain Rating Scale (NPRS), measuring patient satisfaction and behaviour scores in the long-acting opioid group using the NIH PROMIS Parent Proxy Report Scale, and finally evaluating pain levels in the long-acting opioid group using NPRS."